PPRNet - Primary (Care) Practices Research Network
Controller treatment for patients with asthma 5 years of age and older
Inhaled corticosteroids, long-acting beta 2-agonists and leukotriene modifiers are current treatment options for long-term control of asthma. Strong evidence from clinical trials has established that inhaled corticosteroids improve control of asthma for children with mild or moderate persistent asthma compared to as-needed ß2-agonists, as measured by pre-bronchodilator forced expiratory volume in one second (FEV1), reduced airway hyperresponsiveness, improvements in symptom scores and symptom frequency, fewer courses of oral corticosteroids, and fewer urgent care visits or hospitalizations. Studies comparing inhaled corticosteroids to cromolyn, nedocromil, theophylline, or leukotriene receptor antagonists are limited, but available evidence shows that none of these long-term control medications appear to be as effective as inhaled corticosteroids in improving asthma outcomes.
Upper Respiratory Infections
Antibiotics should be avoided in uncomplicated upper respiratory infections, including the common cold, pharyngitis, or acute bronchitis
The CDC states that antibiotics should not be used to treat upper repiratory tract infections, which are largely viral, with antibiotics. They state that unsing antibiotics for these illneses will NOT cure the infection, prevent the infection from spreading to others, or help the patient feel better.
Reference: CDC: Appropriate Antibiotic Use